RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 10.122
EU - Europa 7.468
AS - Asia 4.897
SA - Sud America 631
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 70
OC - Oceania 7
Totale 23.758
Nazione #
US - Stati Uniti d'America 9.921
CN - Cina 1.855
IE - Irlanda 1.649
SG - Singapore 1.601
UA - Ucraina 1.101
IT - Italia 1.038
RU - Federazione Russa 918
SE - Svezia 858
DE - Germania 611
BR - Brasile 516
FR - Francia 476
HK - Hong Kong 420
FI - Finlandia 375
IN - India 295
TR - Turchia 252
VN - Vietnam 208
GB - Regno Unito 169
CA - Canada 80
CZ - Repubblica Ceca 60
BD - Bangladesh 59
NL - Olanda 55
AR - Argentina 36
MX - Messico 36
BE - Belgio 34
JP - Giappone 31
AT - Austria 28
ES - Italia 28
IQ - Iraq 27
PL - Polonia 24
ZA - Sudafrica 22
PK - Pakistan 20
EC - Ecuador 19
GT - Guatemala 17
CR - Costa Rica 16
ID - Indonesia 16
CL - Cile 14
VE - Venezuela 14
PH - Filippine 13
PY - Paraguay 12
AZ - Azerbaigian 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
UZ - Uzbekistan 11
HN - Honduras 10
SA - Arabia Saudita 10
EU - Europa 9
KE - Kenya 9
CO - Colombia 8
MY - Malesia 8
IL - Israele 7
AE - Emirati Arabi Uniti 6
CW - ???statistics.table.value.countryCode.CW??? 6
IR - Iran 6
JM - Giamaica 6
NI - Nicaragua 6
PR - Porto Rico 6
TT - Trinidad e Tobago 6
EE - Estonia 5
ET - Etiopia 5
RO - Romania 5
SV - El Salvador 5
UY - Uruguay 5
AU - Australia 4
EG - Egitto 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GP - Guadalupe 3
HR - Croazia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CM - Camerun 2
DZ - Algeria 2
KW - Kuwait 2
QA - Qatar 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
Totale 23.193
Città #
Dublin 1.649
San Jose 1.512
Chandler 999
Ashburn 918
Singapore 802
Jacksonville 773
Nyköping 548
Dearborn 541
Hong Kong 414
Munich 412
Nanjing 380
Beijing 344
Santa Clara 263
Dallas 261
New York 251
Wilmington 239
Council Bluffs 212
Helsinki 206
Princeton 183
Columbus 176
Lauterbourg 169
San Mateo 157
Nanchang 145
Ann Arbor 122
Boardman 119
Los Angeles 118
Moscow 117
Foggia 101
Shenyang 85
Bari 84
Woodbridge 83
The Dalles 80
Des Moines 74
Ho Chi Minh City 73
Milan 69
Tianjin 69
Hebei 68
Rome 62
Seattle 59
Brno 53
Kunming 51
Phoenix 48
Hanoi 47
Jiaxing 45
Changsha 44
Fresno 39
São Paulo 38
Pune 37
Hangzhou 34
Shanghai 33
Jinan 30
Toronto 30
Brussels 29
Falls Church 29
Guangzhou 28
Tokyo 28
Brooklyn 27
Atlanta 25
Hilden 25
Zhengzhou 25
Ningbo 23
San Francisco 23
New Providence 22
Houston 21
Naples 21
Augusta 20
Frankfurt am Main 20
Warsaw 20
London 19
North Bergen 19
Rio de Janeiro 19
Noci 17
Norwalk 17
Taizhou 17
Changchun 16
Chicago 16
Florence 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Belo Horizonte 14
Orem 14
Auburn Hills 13
Cincinnati 13
Manchester 13
Catania 12
Hillsboro 12
Mexico City 12
Nuremberg 12
Chennai 11
Paris 11
Turku 11
Vienna 11
Boston 10
Guatemala City 10
Manfredonia 10
Philadelphia 10
Saint Petersburg 10
Stockholm 10
Amman 9
Totale 14.282
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 532
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 300
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 284
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 274
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 271
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 194
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 190
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 184
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 180
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 176
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 174
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 169
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 169
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 168
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 167
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 166
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 166
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 165
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 163
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 161
cell carcinoma cell line and use thereof. 160
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 160
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 159
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 158
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 154
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 151
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 151
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 150
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 147
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 147
Renal cortical complement C3 gene expression in IgA nephropathy 146
IgA nephropathy: pros and cons for a familial disease. 144
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 144
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 144
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 143
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 143
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 143
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 141
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 141
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 140
Renal and upper urinary tract tumors: what the nephrologist should know 138
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 137
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 137
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 137
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 136
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 136
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 136
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 136
Renal Carcinoma Cell Line and Use Thereof 134
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 134
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 134
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 133
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 133
Linea cellulare di carcinoma renale e suo uso 133
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 132
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 132
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 131
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 131
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 131
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 131
Biosimilar: can we manage biopharmaceutical heterogeneity? 130
Salivary proteomic signatures of oral squamous cell carcinoma. 130
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 129
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 129
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 128
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 127
Diagnostic and prognostic markers of renal cell carcinoma 127
Reclassification of glomerulopathies: which role for the podocyte? 126
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 126
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 126
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 125
Urinary epidermal growth factor concentration in patients affected by ADPKD. 125
Altered expression of the clock gene machinery in kidney cancer patients 125
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 125
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 124
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 123
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 123
Is Berger's disease a hereditary nephritis? 122
Monitoring biological action of rapamycin in renal transplantation. 122
Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy 122
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review 122
Growth factors and their receptors in the progression of renal damage. 120
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 120
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 120
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 120
Expression of transforming growth factor-beta 1 in thyroid tumor 119
Immunologic Response to RCC. 119
Interferon-alpha (IFN-alpha) –conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients 119
Platelet-derived growth factor and proliferative glomerulonephritis. 118
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 118
Gene expression of the MAGE-1, -3, and -6 antigens in hepatic carcinoma 117
Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. 117
TLR7 and TLR8 as targets for tumor immunotherapy 117
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 116
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 115
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 115
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 115
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 115
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 114
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 112
Totale 14.763
Categoria #
all - tutte 122.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022952 0 0 0 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.410 196 47 113 103 125 454 481 268 815 175 334 299
2025/20265.708 322 509 556 690 277 214 1.317 590 432 407 155 239
2026/20271.958 113 470 575 800 0 0 0 0 0 0 0 0
Totale 23.758